Form D · Other Technology

Tava Health, Inc.

Salt Lake City, UT · CIK 0001810141

Offering snapshot reported Apr 21, 2026 · SEC filing

Reported sold
$35M
Offering amount: $35M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 4, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 21, 2026Initial$34,999,993No comparison7SEC filing
Dec 29, 2023Initial$15,999,997No comparison4SEC filing
Jun 10, 2022Initial$9,999,986No comparison13SEC filing
Jun 3, 2020Initial$2,944,998No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-581302

Source: Form D, filed Apr 21, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dallen Allred Director, Executive
Matt Christensen Director
Kapil Desai Director
Spencer Gardner Director
Sarah Kim Director
Randall Lloyd Director
Jason Ockey Director, Executive
Ilana Stern Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
222 E 7 Th Avenue
Salt Lake City, UT, 84103